LUCID CAPITAL MARKETS Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Envoy Medical (NASDAQ:COCH) with a Buy rating and announces Price Target of $2.